The results of nonprotocol treatment of 232 patients with small cell l
ung cancer seen by a group of community-based medical oncologists over
a 13-year period were evaluated. Factors associated with improved sur
vival also were assessed. The following patient characteristics signif
icantly improved survival: limited stage of disease at diagnosis, trea
tment of extensive (but not limited) disease with regimens including e
toposide and cisplatin, tumor resection, age younger than 70 years, ra
diation therapy to the chest, and female sex (extensive disease only).
Comparison of the data from this study with published results of prot
ocol studies showed similar outcomes.